Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Companies Get Yet More Time To Assess Nitrosamine Risk In EU
Deadline For Assessing Chemical Medicines Extended Until 31 March 2021
Aug 07 2020
•
By
Vibha Sharma
Nitrosamines are classified as probable human carcinogens • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Europe
More from Geography